ConductScience.org, home

Paper90177

Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.

Bartsch G and 3 others. J Urol, 1979. Cited by 237 papers, by iCite.

Cite this record

ConductScience Library. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. Papers, record 90177. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90177

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
PubMed
Journal
J Urol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
237
iCite
Relative citation ratio, by iCite
9.46
iCite
Revised in PubMed
2019-06-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bartsch GG
2Müller HRH R
3Oberholzer MM
4Rohr HPH P

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProstateMajor topic
Prostatic HyperplasiaMajor topic
Adult
Cell Nucleus
Cytological Techniques
Humans
Male
Models, Biological

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 237 citations.

PMIDTitleJournalYearIn PapersSource
41832222A single cell transcriptional profile of benign prostatic hyperplasia.Sci Rep2026https://conductscience.org/library/papers/41832222PubMed
41288675[Acute urinary retention].Urologie2026https://conductscience.org/library/papers/41288675PubMed
39421674Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway.Front Pharmacol2024https://conductscience.org/library/papers/39421674PubMed
37916442New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023.Neurourol Urodyn2024https://conductscience.org/library/papers/37916442PubMed
35268367Efficacy and Safety of the Sandwich Method in Patients with Benign Prostate Hyperplasia: Bipolar Transurethral Resection with GreenLight Vaporization.J Clin Med2022https://conductscience.org/library/papers/35268367PubMed
33737570Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate.Sci Rep2021https://conductscience.org/library/papers/33737570PubMed
31094703Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.JCI Insight2019https://conductscience.org/library/papers/31094703PubMed
28328188Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit".Int Braz J Urol2017https://conductscience.org/library/papers/28328188PubMed
24454597The relationship between bladder wall thickness and lower urinary tract symptoms: Does bladder wall thickness change after alpha-blocker therapy with alfuzosin?Can Urol Assoc J2014https://conductscience.org/library/papers/24454597PubMed
23872639Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression.Organogenesis2013https://conductscience.org/library/papers/23872639PubMed
23852618Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.Age (Dordr)2014https://conductscience.org/library/papers/23852618PubMed
22474290Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.J Biol Chem2012https://conductscience.org/library/papers/22474290PubMed
18231614Alpha blockers for the treatment of benign prostatic hyperplasia.Rev Urol2007https://conductscience.org/library/papers/18231614PubMed
17215999The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.Rev Urol2006https://conductscience.org/library/papers/17215999PubMed
16985970A Primary Care Physician's Perspective on Benign Prostatic Hyperplasia.Rev Urol2003https://conductscience.org/library/papers/16985970PubMed
16985855Evaluating men with benign prostatic hyperplasia.Rev Urol2004https://conductscience.org/library/papers/16985855PubMed
16465187Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.Br J Pharmacol2006https://conductscience.org/library/papers/16465187PubMed
12882718The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.Curr Urol Rep2003https://conductscience.org/library/papers/12882718PubMed
12084322The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.Curr Urol Rep2000https://conductscience.org/library/papers/12084322PubMed
10369476Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin.Br J Pharmacol1999https://conductscience.org/library/papers/10369476PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/90177

GET https://conductscience.org/api/papers/v1/90177/cited_by?page=2